Biphasic Cuirass Ventilation (BCV) is a form of non-invasive external ventilation that applies alternating negative and positive pressure to the chest wall using a shell known as a cuirass.
BCV is delivered using the Hayek RTX Respirator, which is indicated for external ventilation of the lungs resulting in gas exchange and for assisting patients with secretion clearance management, when prescribed by a qualified healthcare professional.
BCV differs from mask-based ventilation by applying pressure externally to the thorax rather than through the airway. This external approach may be considered by clinicians when non-invasive ventilatory support or secretion management is appropriate.
Biphasic Cuirass Ventilation (BCV) is a form of non-invasive external ventilation delivered using a cuirass shell applied to the chest wall. The cuirass forms a seal over the thorax and allows externally applied pressure changes to interact with normal chest wall movement during breathing.
During use, the Hayek RTX Respirator generates controlled pressure changes within the cuirass shell. These pressure changes are configured by the clinician to support ventilation by assisting inspiration and expiration, resulting in gas exchange, without the need for an airway-based interface. The device settings, timing, and modes of operation are determined by the prescribing clinician based on individual patient needs.
In addition to ventilation support, the device may be configured to assist with secretion clearance management. Secretion clearance support may include clinician-directed use of externally applied chest wall vibration intended to assist with mobilization of secretions, as well as cough phase designed to support expectoration as part of an overall secretion clearance approach. Device configuration and use are determined by the prescribing clinician in accordance with the prescribed plan of care.
Some patients may not tolerate face mask–based interfaces. In appropriate cases, clinicians may consider external ventilation approaches such as BCV delivered using the Hayek RTX Respirator.
BCV is delivered using an external cuirass interface applied to the chest wall and does not require placement of an invasive airway. Patient selection, interface choice, and airway management decisions are determined by the treating clinician.
The Hayek RTX Respirator is a single, prescription medical device that may be configured by clinicians to provide non-invasive external ventilation resulting in gas exchange and to assist with secretion clearance management using a cuirass interface applied to the chest wall.
When prescribed by a healthcare professional, the device may support multiple respiratory care functions within one system. Secretion clearance support may include clinician-directed use of externally applied chest wall vibration intended to assist with mobilization of secretions, as well as cough phase designed to support expectoration as part of an overall secretion clearance approach.
